Literature DB >> 27460506

An extract from pork bones containing osteocalcin improves glucose metabolism in mice by oral administration.

Akiko Mizokami1,2, DaGuang Wang1, Mitsuru Tanaka3, Jing Gao1, Hiroshi Takeuchi4, Toshiro Matsui3, Masato Hirata1.   

Abstract

Osteocalcin (OC) is a bone-derived hormone that regulates energy metabolism. OC exists in two forms, carboxylated (GlaOC) and uncaboxylated (GluOC), but only the latter appears to have an endocrine function. In this study, we prepared an extract containing both Gla- and GluOC from boiled pork bone using 0.2 M carbonate buffer at pH 9.5, and tested whether the extract had beneficial effects on improving metabolic parameters in obese mice. The extract equivalent of 1.2 μg of GluOC/mouse was orally administrated to C57BL/6 female mice fed a high-fat, high-sucrose diet. Daily oral administration of the extract for four weeks decreased blood glucose levels and promoted glucose tolerance as well as insulin sensitivity. Our study shows for the first time that boiled pork bones are a source material for osteocalcin in the large-scale production of supplements designed to improve glucose metabolism.

Entities:  

Keywords:  adipocyte; glucose metabolism; oral administration; osteocalcin; pork bone

Year:  2016        PMID: 27460506     DOI: 10.1080/09168451.2016.1214530

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  The facts of the matter: What is a hormone?

Authors:  Gerard Karsenty
Journal:  PLoS Genet       Date:  2020-06-26       Impact factor: 5.917

2.  Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300.

Authors:  Takahito Otani; Miho Matsuda; Akiko Mizokami; Norio Kitagawa; Hiroshi Takeuchi; Eijiro Jimi; Tetsuichiro Inai; Masato Hirata
Journal:  Cell Death Dis       Date:  2018-12-13       Impact factor: 8.469

Review 3.  Osteocalcin and the physiology of danger.

Authors:  Julian Meyer Berger; Gerard Karsenty
Journal:  FEBS Lett       Date:  2022-01-21       Impact factor: 3.864

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.